BIT225
id:
bit225-250-1350459
title:
BIT225
text:
BIT225 is an experimental drug candidate under development by Biotron Limited for use in the treatment of both HIV and hepatitis C infection. By blocking Vpu ion channel activity, it disrupts HIV assembly within host monocyte cells; its method of action is a first for HIV drugs. Because it targets replication in monocyte derived macrophages, it offers promise for treatment of viral reservoirs that are unaffected by standard treatments. The activity of BIT225 is post-virus integration, with no di
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/BIT225
date created:
date modified:
2023-12-01T20:41:13Z
main entity:
{"identifier":"Q18355839","url":"https://www.wikidata.org/entity/Q18355839"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/0c/BIT225.svg","width":1185,"height":1080}
fields total:
13
integrity:
15